Novavax, Inc. Logo Image

Novavax, Inc.

Novavax, Inc. Banner Image

Most Recent Annual Report

2015 Annual Report and Form 10K

Novavax, Inc.

Novavax, Inc. does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Novavax, Inc.

501-1000 Employees
Based in Gaithersburg, Maryland

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant vaccines for infectious diseases using its virus-like particle platform (VLP) technology. It develops vaccine product candidates that target pandemic influenza, including H1N1 and H5N1 strains; seasonal influenza; and respiratory syncytial virus (RSV).

Ticker:
NVAX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol